Literature DB >> 22160863

Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain.

George K Shinomol1, Rajeswara Babu Mythri, M M Srinivas Bharath.   

Abstract

Bacopa monnieri (BM), an ayurvedic medicinal herb is widely known for its memory enhancing ability and improvement of brain function. In this study, we tested the hypothesis that BM extract (BME) could offset neurotoxicant-induced oxidative dysfunctions in developing brain in a rotenone (ROT) mouse model. Pretreatment of dopaminergic (N27 cell lines) cells with BME exhibited significant cytoprotective effect as evidenced by the attenuation of ROT-induced oxidative stress and cell death. Further, the neuroprotective efficacy of BME was assessed in prepubertal mice administered ROT (i.p. 1.0 mg/kg b.w./day) for 7 days. BME treatment significantly offset ROT-induced oxidative damage in striatum (St) and other brain regions as evident by the normalized levels of oxidative markers (malondialdehyde, ROS levels, and hydroperoxides) and restoration of depleted GSH levels. Further, BME effectively normalized the protein carbonyl content in all brain regions suggesting its ability to prevent protein oxidation. Furthermore, BME treatment restored the activity levels of cytosolic antioxidant enzymes, neurotransmitter function, and dopamine levels in St. Based on our findings, we hypothesize that the neuroprotective effects of BM extract may be at least in part related to its ability to enhance reduced glutathione and antioxidant defenses in brain regions. It is suggested that BM may be effectively exploited as a prophylactic/therapeutic adjuvant for neurodegenerative disorders involving oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160863     DOI: 10.1007/s10571-011-9776-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  47 in total

1.  Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra.

Authors:  M J Marti; C J James; T F Oo; W J Kelly; R E Burke
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

2.  Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity.

Authors:  Jürgen G Okun; Friederike Hörster; Lilla M Farkas; Patrik Feyh; Angela Hinz; Sven Sauer; Georg F Hoffmann; Klaus Unsicker; Ertan Mayatepek; Stefan Kölker
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

3.  PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.

Authors:  Gang Wang; Chen Qi; Guo-Hua Fan; Hai-Yan Zhou; Sheng-Di Chen
Journal:  FEBS Lett       Date:  2005-07-18       Impact factor: 4.124

4.  Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.

Authors:  Pooja Jadiya; Asif Khan; Shreesh Raj Sammi; Supinder Kaur; Snober S Mir; Aamir Nazir
Journal:  Biochem Biophys Res Commun       Date:  2011-09-08       Impact factor: 3.575

5.  Glutathione modulates Ca(2+) influx and oxidative toxicity through TRPM2 channel in rat dorsal root ganglion neurons.

Authors:  Mustafa Nazıroğlu; Cemil Özgül; Bilal Çiğ; Salih Doğan; Abdulhadi Cihangir Uğuz
Journal:  J Membr Biol       Date:  2011-07-12       Impact factor: 1.843

Review 6.  Selective vulnerability in the developing central nervous system.

Authors:  Patrick S McQuillen; Donna M Ferriero
Journal:  Pediatr Neurol       Date:  2004-04       Impact factor: 3.372

7.  Differential induction of oxidative impairments in brain regions of male mice following subchronic consumption of Khesari dhal (Lathyrus sativus) and detoxified Khesari dhal.

Authors:  George K Shinomol
Journal:  Neurotoxicology       Date:  2007-03-12       Impact factor: 4.294

Review 8.  Lessons from the rotenone model of Parkinson's disease.

Authors:  J Timothy Greenamyre; Jason R Cannon; Robert Drolet; Pier-Giorgio Mastroberardino
Journal:  Trends Pharmacol Sci       Date:  2010-01-22       Impact factor: 14.819

9.  Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster.

Authors:  Ravikumar Hosamani
Journal:  Neurotoxicology       Date:  2009-09-08       Impact factor: 4.294

Review 10.  Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition.

Authors:  Massimiliano Di Filippo; Barbara Picconi; Cinzia Costa; Vincenza Bagetta; Michela Tantucci; Lucilla Parnetti; Paolo Calabresi
Journal:  Eur J Pharmacol       Date:  2006-06-16       Impact factor: 4.432

View more
  11 in total

1.  Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice.

Authors:  Girish Chandran
Journal:  Cell Mol Neurobiol       Date:  2013-07-19       Impact factor: 5.046

2.  Prophylactic neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence.

Authors:  Sriranjini Venkata Rao; P Hemalatha; S Yetish; M Muralidhara; Padmanabhan S Rajini
Journal:  Metab Brain Dis       Date:  2019-06-18       Impact factor: 3.584

Review 3.  Neuropharmacological review of the nootropic herb Bacopa monnieri.

Authors:  Sebastian Aguiar; Thomas Borowski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

4.  Oral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: relevance to Parkinson's disease.

Authors:  Krishna Gokul
Journal:  Neurochem Res       Date:  2014-05-16       Impact factor: 3.996

5.  Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson's Disease.

Authors:  Osmar Vieira Ramires Júnior; Barbara da Silva Alves; Paula Alice Bezerra Barros; Jamile Lima Rodrigues; Shana Pires Ferreira; Linda Karolynne Seregni Monteiro; Gabriela de Moraes Soares Araújo; Sara Silva Fernandes; Gustavo Richter Vaz; Cristiana Lima Dora; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2021-04-16       Impact factor: 3.978

6.  Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.

Authors:  Ching-Chi Chiu; Tu-Hsueh Yeh; Szu-Chia Lai; Yah-Huei Wu-Chou; Che-Hong Chen; Daria Mochly-Rosen; Yin-Cheng Huang; Yu-Jie Chen; Chao-Lang Chen; Ya-Ming Chang; Hung-Li Wang; Chin-Song Lu
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

7.  Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease.

Authors:  Loubna Boukhzar; Abdallah Hamieh; Dorthe Cartier; Yannick Tanguy; Ifat Alsharif; Matthieu Castex; Arnaud Arabo; Sana El Hajji; Jean-Jacques Bonnet; Mohammed Errami; Anthony Falluel-Morel; Abdeslam Chagraoui; Isabelle Lihrmann; Youssef Anouar
Journal:  Antioxid Redox Signal       Date:  2016-03-16       Impact factor: 8.401

Review 8.  Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Hyung-Woo Lim; Soon-Min Hong; Dong-Kug Choi
Journal:  Molecules       Date:  2012-09-26       Impact factor: 4.411

9.  Effects of five Ayurvedic herbs on locomotor behaviour in a Drosophila melanogaster Parkinson's disease model.

Authors:  R L M Jansen; B Brogan; A J Whitworth; E J Okello
Journal:  Phytother Res       Date:  2014-08-04       Impact factor: 5.878

10.  A Special Extract of Bacopa monnieri (CDRI-08) Restores Learning and Memory by Upregulating Expression of the NMDA Receptor Subunit GluN2B in the Brain of Scopolamine-Induced Amnesic Mice.

Authors:  Rakesh Rai; Hemant K Singh; S Prasad
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.